Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(27)
OTHER(5)
DRUG(3)
RADIATION(1)
Cetuximab
6 trials
phase_1phase_1_2phase_2phase_3
washington-university-school-of-medicine
Cisplatin
4 trials
phase_2
washington-university-school-of-medicine
Pembrolizumab
2 trials
phase_1phase_2
washington-university-school-of-medicine
Intensity modulated radiation therapy
2 trials
phase_2
washington-university-school-of-medicine
PD 0332991
2 trials
phase_1_2phase_3
washington-university-school-of-medicine
Surgery
2 trials
phase_2
washington-university-school-of-medicine
Neck Dissection Impairment Index
1 trial
phase_2
washington-university-school-of-medicine
Peripheral blood draw
1 trial
phase_2
washington-university-school-of-medicine

+16 more interventions

24 unique interventions4 categories

Analytics

Trial Phases

Phase 13
Phase 28
Phase 31

Trial Status

Completed7
Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator11
PI Rate100%

Activity Timeline

Clinical Trials (11)

NCT06702033Phase 2Recruiting
The Minimalist Trial-2
HPV-Related Oropharynx Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2025-04-10
NCT04966481Phase 3Recruiting
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
HPV-unrelated Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2022-04-06
NCT04643379Phase 2Active Not Recruiting
Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2021-08-07
NCT04624113Phase 1Terminated
Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2021-04-14
NCT03621696Phase 2Completed
Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"
HPV Related Oropharyngeal Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2018-10-23
NCT02573493Phase 2Completed
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Cancer of Head and NeckCancer of the Head and NeckCarcinoma, Squamous Cell of the Head and Neck+3 more
PrincipalinvestigatorStart date: 2016-04-13
NCT02101034Phase 1/2Completed
PD 0332991 and Cetuximab in Patients With Incurable SCCHN
Carcinoma, Squamous Cell of Head and Neck
PrincipalinvestigatorStart date: 2014-06-17
NCT01716416Phase 1Completed
Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Squamous Cell Carcinoma of the Head and Neck
PrincipalinvestigatorStart date: 2013-05-31
NCT01566435Phase 2Completed
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
Head and Neck Neoplasms
PrincipalinvestigatorStart date: 2012-08-09
NCT00671437Phase 2Completed
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
Carcinoma, Squamous Cell
Principalinvestigator

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous Cell
Similarity Score8%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Related
17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Head and Neck
Similarity Score5%

Lillian Siu, MD

Princess Margaret Cancer Centre

Related
12 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck
Similarity Score5%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Squamous Cell
Similarity Score5%

Ye Guo, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck
Similarity Score5%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score3%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Head and Neck Neoplasms
Similarity Score3%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score3%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Carcinoma, Squamous Cell
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT06702033Phase 2PrincipalInvestigator

The Minimalist Trial-2

HPV-Related Oropharynx Squamous Cell Carcinoma
Recruiting
NCT04966481Phase 3PrincipalInvestigator

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma
Recruiting
NCT04643379Phase 2PrincipalInvestigator

Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Active Not Recruiting
NCT04624113Phase 1PrincipalInvestigator

Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

Head and Neck Squamous Cell Carcinoma
Terminated
NCT03621696Phase 2PrincipalInvestigator

Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"

HPV Related Oropharyngeal Squamous Cell Carcinoma
Completed
NCT02573493Phase 2PrincipalInvestigator

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Cancer of Head and NeckCancer of the Head and NeckCarcinoma, Squamous Cell of the Head and Neck+3 more
Completed
NCT02101034Phase 1/2PrincipalInvestigator

PD 0332991 and Cetuximab in Patients With Incurable SCCHN

Carcinoma, Squamous Cell of Head and Neck
Completed
NCT01716416Phase 1PrincipalInvestigator

Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)

Squamous Cell Carcinoma of the Head and Neck
Completed
NCT01566435Phase 2PrincipalInvestigator

Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

Head and Neck Neoplasms
Completed
NCT00671437Phase 2PrincipalInvestigator

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Carcinoma, Squamous Cell
Completed
NCT01553851Phase 2PrincipalInvestigator

GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

Mouth NeoplasmsNeoplasms, Oral
Completed

All 11 trials loaded